Signature Wealth Management Group Abb Vie Inc. Transaction History

Signature Wealth Management Group

$240 Million
Q2 2025

A detailed history of Signature Wealth Management Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Signature Wealth Management Group holds 25,009 shares of ABBV stock, worth $5.85 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares

25,009

Previous 24,779 0.93%

Holding current value

$5.85 Million

Previous $5.19 Million 10.58%

% of portfolio

1.94%

Previous 2.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$170.16 - $206.27 $39,136 - $47,442	230 Added 0.93%	25,009 $4.64 Million
Q1 2025 Apr 17, 2025	SELL	$169.2 - $216.66 $113,871 - $145,812	-673 Reduced 2.64%	24,779 $5.19 Million
Q4 2024 Feb 10, 2025	BUY	$164.99 - $203.87 $83,319 - $102,954	505 Added 2.02%	25,452 $4.52 Million
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $248,872 - $302,782	-1,519 Reduced 5.74%	24,947 $4.93 Million
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $121,355 - $141,715	-784 Reduced 2.88%	26,466 $4.54 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $187,788 - $213,967	-1,175 Reduced 4.13%	27,250 $4.96 Million
Q4 2023 Jan 09, 2024	SELL	$137.6 - $154.97 $73,753 - $83,063	-536 Reduced 1.85%	28,425 $4.41 Million
Q2 2023 Jul 10, 2023	BUY	$132.51 - $164.9 $64,267 - $79,976	485 Added 1.7%	28,961 $3.9 Million
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $48,155 - $55,457	-333 Reduced 1.16%	28,476 $4.54 Million
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $132,086 - $158,405	-955 Reduced 3.21%	28,809 $0
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $262,514 - $301,087	-1,956 Reduced 6.17%	29,764 $4 Million
Q2 2022 Jul 14, 2022	SELL	$137.62 - $174.96 $510,157 - $648,576	-3,707 Reduced 10.46%	31,720 $4.86 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $79,847 - $99,068	-605 Reduced 1.68%	35,427 $5.74 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $90,348 - $114,317	-841 Reduced 2.28%	36,032 $4.88 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $30,962 - $35,146	-291 Reduced 0.78%	36,873 $3.98 Million
Q2 2021 Jul 16, 2021	SELL	$105.21 - $117.21 $17,780 - $19,808	-169 Reduced 0.45%	37,164 $4.19 Million
Q1 2021 Apr 15, 2021	SELL	$102.3 - $112.62 $31,099 - $34,236	-304 Reduced 0.81%	37,333 $4.04 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $80,248 - $108,343	997 Added 2.72%	37,637 $4.03 Million
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $257 - $302	3 Added 0.01%	36,640 $3.21 Million
Q2 2020 Jul 20, 2020	SELL	$73.37 - $98.18 $9,758 - $13,057	-133 Reduced 0.36%	36,637 $3.6 Million
Q1 2020 May 26, 2020	SELL	$64.5 - $97.79 $3,741 - $5,671	-58 Reduced 0.16%	36,770 $2.8 Million
Q4 2019 Jan 15, 2020	BUY	$72.13 - $90.25 $60,805 - $76,080	843 Added 2.34%	36,828 $3.26 Million
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $314 - $378	-5 Reduced 0.01%	35,985 $2.73 Million
Q2 2019 Jul 08, 2019	BUY	$65.7 - $83.98 $48,486 - $61,977	738 Added 2.09%	35,990 $2.63 Million
Q1 2019 Apr 17, 2019	BUY	$77.14 - $90.79 $241,602 - $284,354	3,132 Added 9.75%	35,252 $2.84 Million
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $40,559 - $50,021	521 Added 1.65%	32,120 $2.96 Million
Q3 2018 Oct 30, 2018	BUY	$88.91 - $98.84 $159,593 - $177,417	1,795 Added 6.02%	31,599 $2.57 Million
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $45,159 - $53,433	503 Added 1.72%	29,804 $2.76 Million
Q1 2018 Apr 12, 2018	SELL	$92.01 - $123.21 $1.22 Million - $1.64 Million	-13,297 Reduced 31.22%	29,301 $2.77 Million
Q4 2017 Apr 11, 2018	BUY	$89.56 - $98.21 $3.82 Million - $4.18 Million	42,598	42,598 $4.12 Million

Others Institutions Holding ABBV

# of Institutions

4,293

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Signature Wealth Management Group with notifications on news.

Account

Signature Wealth Management Group Abb Vie Inc. Transaction History